Search
for
Sort by
Research 541–570 of 1000+
- The Relationship Between Nutrition Habits, BMI, Anxiety, and Seborrheic Dermatitis
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS)
- 465 Multicenter prospective study on the efficacy of narrowband ultraviolet B treatment and its effect on quality of life, anxiety, depression in plaque psoriasis patients
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males
- [The evaluation of clinical signs and hormonal changes in women who complained of excessive body hair growth].
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Clinical Effectiveness of Two Old Immunosuppressant Drugs, Methotrexate and Azathioprine, in the Treatment of Lichen Planopilaris: A Randomized Clinical Trial
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Multivariate Profiles of Female Sexual Function: A Cluster Analysis of FSFI Domains in Women with and Without PCOS
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Adolescent Male Androgenetic Alopecia with Iron Deficiency Anemia: A Case Treated with Individualized Homeopathy
- Evaluation of Total Oxidant and Total Antioxidant Status in Patients with Acne Vulgaris
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- LB938 Use of a scalp clarifying shampoo in the treatment of lichen planopilaris and female pattern hair loss
- Serum nuclear factor E‐2‐related factor 2 in female pattern hair loss
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials